Source: Endocrine - Related Cancer. Unidades: FSP, EE, IB, FM
Subjects: NEOPLASIA ENDÓCRINA MÚLTIPLA, PROTO-ONCOGENES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TOLEDO, Rodrigo A. et al. Comprehensive assessment of the disputed RET Y791F variant shows no association with medullary thyroid carcinoma susceptibility. Endocrine - Related Cancer, v. 22, n. 2, 2015Tradução . . Disponível em: https://doi.org/10.1530/ERC-14-0491. Acesso em: 25 abr. 2026.APA
Toledo, R. A., Hatakana, R., Lourenço Junior, D. M., Lindsey, S. C., Camacho, C. P., Almeida, M., et al. (2015). Comprehensive assessment of the disputed RET Y791F variant shows no association with medullary thyroid carcinoma susceptibility. Endocrine - Related Cancer, 22( 2). doi:10.1530/ERC-14-0491NLM
Toledo RA, Hatakana R, Lourenço Junior DM, Lindsey SC, Camacho CP, Almeida M, Lima Junior JV, Sekiya T, Garralda E, Naslavsky M, Yamamoto GL, Lazar M, Meirelles O, Sobreira TJP, Lebrão ML, Duarte YA de O, Blangero J, Zatz M, Cerutti JM, Maciel RM de B, Toledo SP de A. Comprehensive assessment of the disputed RET Y791F variant shows no association with medullary thyroid carcinoma susceptibility [Internet]. Endocrine - Related Cancer. 2015 ; 22( 2):[citado 2026 abr. 25 ] Available from: https://doi.org/10.1530/ERC-14-0491Vancouver
Toledo RA, Hatakana R, Lourenço Junior DM, Lindsey SC, Camacho CP, Almeida M, Lima Junior JV, Sekiya T, Garralda E, Naslavsky M, Yamamoto GL, Lazar M, Meirelles O, Sobreira TJP, Lebrão ML, Duarte YA de O, Blangero J, Zatz M, Cerutti JM, Maciel RM de B, Toledo SP de A. Comprehensive assessment of the disputed RET Y791F variant shows no association with medullary thyroid carcinoma susceptibility [Internet]. Endocrine - Related Cancer. 2015 ; 22( 2):[citado 2026 abr. 25 ] Available from: https://doi.org/10.1530/ERC-14-0491
